Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:49:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-13T12:22:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision notes updated from v3.4.0 to v3.4.1 on the page; this does not affect core study content (eligibility, outcomes, locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:27:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a new display for Last Update Posted in the Study Record Dates and removed the Last Update Posted (Estimated) label. This clarifies the timestamp indicating when the study record was last updated.
    Difference
    0.0%
    Check dated 2026-01-22T06:38:50.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated from v3.3.3; no changes to core study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:47:19.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Publications section updated: added Improvements in health-related quality of life in patients with transfusion-dependent beta-thalassemia after exagamglogene autotemcel (Blood Advances, 2025, DOI: 10.1182/bloodadvances.2025016702) and removed the earlier ahead-of-print version of the same study. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-08T01:36:38.000Z thumbnail image

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.